Article Public (all visitors)

Alzheimer’s Treatments Showing Early Promise

AARP 2021

A small study has found that the experimental drug donanemab may slow cognitive decline in Alzheimer's patients. It joins others that show promise.

Show More
View Original Source

Curated by

FoundryBase

Updated 10 months ago

ACADEMIC RESEARCH   BRAIN   HEALTHCARE   MEDICINE   PSYCHOLOGY  

Save

Bookmark this resource

Browse more

View all Articles

Continue from source

More from source

Browse more from AARP

Contribute to FoundryBase

Found something worth adding?

Sign in to suggest resources and start building your own collection.

Log in to suggest Create account